Mirae Asset Healthcare Fund Regular IDCW
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 02-07-2018
AUM:
₹ 2,795.84 Cr
Expense Ratio
1.93%
Benchmark
BSE Healthcare TRI
ISIN
INF769K01EB0
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
99
Fund Manager
Mr. Vrijesh Kasera, Mr. Tanmay Mehta
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Mirae Asset Healthcare Fund Regular IDCW | -2.2 | 19.01 | 15.5 |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
24.615
Last change
-0.09 (-0.3656%)
Fund Size (AUM)
₹ 2,795.84 Cr
Performance
19.59% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns. There is no assurance that the investment objective of the scheme will be achieved.
Fund Manager
Mr. Vrijesh Kasera, Mr. Tanmay Mehta
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 10.92 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.15 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 6.79 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 6.32 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.3 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 6.02 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.94 |
| Dr. Reddys Laboratories Ltd | 4.27 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.89 |
| Krishna Institute Of Medical Sciences Limited | 3.82 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 97.47 |
| Chemicals | 1.31 |
| Information Technology | 0.83 |
